To mark World Cancer Research Day on 24 September 2018, the Australian Cancer Research Foundation (ACRF) is pleased to announce new collaborations with Australian Prostate Centre, Ovarian Cancer Research Foundation (OCRF) and the Snowdome Foundation. This will further enhance cancer research capacity in Australia and increase collaboration between cancer research funders.
ACRF provides outstanding Australian researchers with state-of-the-art equipment they need to improve prevention, diagnosis and treatment of all types of cancer. The new collaborations will provide additional funds to support personnel that operates equipment acquired with an ACRF grant. This ensures that the equipment will be used for maximum impact and efficiency.
ACRF Chief Executive Officer Professor Ian Brown says that the new collaborations are an excellent way to enhance the impact and improve the efficiency of funding for Australian cancer research.
“The benefit of the collaborations announced today mark a significant saving on resources and time for researchers. Less time will be spent on writing additional funding applications, allowing researchers to spend time on what really matters – cancer research.”
ACRF grant applications are assessed annually by the Medical Research Advisory Committee, comprising esteemed Australian and international cancer researchers and clinicians who volunteer their time. The Committee ensures that the most promising and impactful cancer research initiatives in Australia are recommended to the Board of Trustees to receive ACRF funding.
“These collaborations are a tremendous acknowledgement of the reputation and integrity of ACRF and its grant selection and governance procedures. We look forward to giving researchers not only the most advanced tools they need to outsmart cancer, but also simplifying the provision of human power to make it all happen.”
OCRF Chief Executive Officer Lucinda Nolan believes that collaborating with likeminded cancer research charities is a smarter way to progress towards shared goals.
“Collaboration makes us stronger, smarter and more efficient.” Ms Nolan says.
“Joint grants will unlock additional funding for ovarian cancer researchers and improve our ability to support a broader range of projects. This partnership is an exciting development for us and will hopefully accelerate progress within the research field.”
Mark Harrison, CEO at the Australian Prostate Centre says: “We are proud to be collaborating with ACRF in recognising and supporting potentially lifesaving cancer research in Australia. This agreement will accelerate research outcomes to benefit all Australian men with prostate cancer.”
Snowdome CEO Miriam Dexter says “The Snowdome Foundation is pleased to be collaborating with ACRF to advance translational blood cancer research. ACRF brings a national approach as well as a transparent, peer-reviewed grant review process. Further, by leveraging each organisations’ key funding focus, we are able to match hi-tech equipment with vital human infrastructure resulting in fast-tracking next-generation blood cancer treatments and ‘making hope real’ for Australian blood cancer patients.”
The current agreements will be in place until 2020.